Specialties

A post hoc analysis of the DECLARE-TIMI 58 trial may provide a new compelling indication for dapagliflozin.

Initiating the right medications upon diabetes diagnosis can help mitigate heart attack risk. 

Diabetes management can be a major factor in renal transplant aftercare; can DPP-4 therapy help improve outcomes?

Patients with psoriatic arthritis may be more prone to develop type 2 diabetes than the general population.

SGLT2 inhibitors compared to DPP-4 inhibitors: which showed a favorable effect on MACE? 

Weight loss is a significant lifestyle modification that can affect both diabetes and the risk for some cancers.

Finerenone, which treats CKD, may also help to reduce cardiac failure in type 2. 

The CARDIA study explored the link to the decline in cognitive abilities in diseases like Alzheimer's and Parkinson's in middle-aged populations.

Cardiovascular events and diabetes go hand in hand, but what if there’s already a drug out there to lower the risk of those events?  

A study based on the Look AHEAD trial examined how weight loss and physical activity impact the risk of HF, MI, and T2DM.